![Selective Estrogen Receptor Modulators in the Ruthenocene Series. Synthesis and Biological Behavior | Journal of Medicinal Chemistry Selective Estrogen Receptor Modulators in the Ruthenocene Series. Synthesis and Biological Behavior | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm049268h/asset/images/large/jm049268hn00001.jpeg)
Selective Estrogen Receptor Modulators in the Ruthenocene Series. Synthesis and Biological Behavior | Journal of Medicinal Chemistry
![Yvelines : dans cet hébergement de la Croix-Rouge, on vit avec les cafards et les punaises de lit | 78actu Yvelines : dans cet hébergement de la Croix-Rouge, on vit avec les cafards et les punaises de lit | 78actu](https://static.actu.fr/uploads/2022/11/25398-221114180154684-0.jpg)
Yvelines : dans cet hébergement de la Croix-Rouge, on vit avec les cafards et les punaises de lit | 78actu
![Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study - Tison - 2019 - Arthritis & Rheumatology - Wiley Online Library Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study - Tison - 2019 - Arthritis & Rheumatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/00764f2a-6eec-49b5-9196-ec826282d86c/art.v71.12.cover.jpg?trick=1667147453420)
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study - Tison - 2019 - Arthritis & Rheumatology - Wiley Online Library
Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GF
![New‐onset vitiligo and progression of pre‐existing vitiligo during treatment with biological agents in chronic inflammatory diseases - Méry‐Bossard - 2017 - Journal of the European Academy of Dermatology and Venereology - Wiley New‐onset vitiligo and progression of pre‐existing vitiligo during treatment with biological agents in chronic inflammatory diseases - Méry‐Bossard - 2017 - Journal of the European Academy of Dermatology and Venereology - Wiley](https://onlinelibrary.wiley.com/cms/asset/cb255038-d297-4749-a8f8-ce96e5929e2e/jdv.2017.31.issue-1.cover.jpg)
New‐onset vitiligo and progression of pre‐existing vitiligo during treatment with biological agents in chronic inflammatory diseases - Méry‐Bossard - 2017 - Journal of the European Academy of Dermatology and Venereology - Wiley
![European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline - Bischoff - 2022 - United European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline - Bischoff - 2022 - United](https://onlinelibrary.wiley.com/cms/asset/82442bc6-1cad-40ca-8868-16dc10238809/ueg2.v10.7.cover.jpg?trick=1671597528345)